New multimodal intervention to reduce irritable bowel syndrome (IBS) severity symptoms-Pilot study with a 12 month follow-up.
Maximilian HinseAnja ThronickeAnne BerghöferHarald MatthesPublished in: PloS one (2022)
Our findings suggest that an 8-week program of AMT improves the severity of IBS with an ongoing effect at a 12 month follow-up. Especially for patients without psychological comorbidities, AMT is very successful. Future IBS therapies should incorporate a modified multimodal concept with stronger psychological therapy modules in parallel for patients with depression and anxiety.
Keyphrases
- irritable bowel syndrome
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- sleep quality
- pain management
- prognostic factors
- peritoneal dialysis
- clinical trial
- depressive symptoms
- quality improvement
- patient reported outcomes
- current status
- mesenchymal stem cells
- study protocol
- patient reported
- cell therapy